{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:05Z","timestamp":1790380025965,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5T32GM086330-03"],"award-info":[{"award-number":["5T32GM086330-03"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201000003I"],"award-info":[{"award-number":["HHSN275201000003I"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01-HD081044-01"],"award-info":[{"award-number":["1R01-HD081044-01"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001115-03"],"award-info":[{"award-number":["KL2TR001115-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001117"],"award-info":[{"award-number":["UL1TR001117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["1R18-FD005292-01"],"award-info":[{"award-number":["1R18-FD005292-01"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHS0100201300009C"],"award-info":[{"award-number":["HHS0100201300009C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00246-016-1496-2","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:20:17Z","timestamp":1478564417000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care Unit"],"prefix":"10.1007","volume":"38","author":[{"name":"on behalf of the Best Pharmaceuticals for Children Act \u2013 Pediatric Trials Network Steering Committee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanecia","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reese H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2125.1993.tb04180.x","volume":"35","author":"JP Dutertre","year":"1993","unstructured":"Dutertre JP, Billaud EM, Autret E, Chantepie A, Oliver I, Laugier J (1993) Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure. Br J Clin Pharmacol 35:528\u2013530","journal-title":"Br J Clin Pharmacol"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/adc.64.2.219","volume":"64","author":"M Frenneaux","year":"1989","unstructured":"Frenneaux M, Stewart RA, Newman CM, Hallidie-Smith KA (1989) Enalapril for severe heart failure in infancy. Arch Dis Child 64:219\u2013223","journal-title":"Arch Dis Child"},{"key":"1496_CR3","first-page":"128","volume":"78","author":"M Hanssens","year":"1991","unstructured":"Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA (1991) Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78:128\u2013135","journal-title":"Obstet Gynecol"},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-2007-994783","volume":"9","author":"T Mason","year":"1992","unstructured":"Mason T, Polak M, Pyles L, Mullett M, Swanke C (1992) Treatment of neonatal renovascular hypertension with intravenous enalapril. Am J Perinatol 9:254\u2013257","journal-title":"Am J Perinatol"},{"key":"1496_CR5","unstructured":"BTA Pharmaceuticals, Inc. VASOTEC (enalapril maleate) tablet [updated June 2010]. \n                    http:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=5d181743-a0fc-4d17-953d-b17a936f9ecc"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jash.2011.08.001","volume":"5","author":"DL Blowey","year":"2011","unstructured":"Blowey DL, Duda PJ, Stokes P, Hall M (2011) Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 5:478\u2013483","journal-title":"J Am Soc Hypertens"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00467-010-1755-z","volume":"27","author":"JM Dionne","year":"2012","unstructured":"Dionne JM, Abitbol CL, Flynn JT (2012) Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 27:17\u201332","journal-title":"Pediatr Nephrol"},{"key":"1496_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ajh\/5.2.51","volume":"5","author":"HP Singh","year":"1992","unstructured":"Singh HP, Hurley RM, Myers TF (1992) Neonatal hypertension. Incidence and risk factors. Am J Hypertens 5:51\u201355","journal-title":"Am J Hypertens"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","volume":"122","author":"DT Hsu","year":"2010","unstructured":"Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC et al (2010) Enalapril in infants with single ventricle results of a multicenter randomized trial. Circulation 122:333\u2013340","journal-title":"Circulation"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00246-013-0813-2","volume":"35","author":"KA Lindle","year":"2014","unstructured":"Lindle KA, Dinh K, Moffett BS, Kyle WB, Montgomery NM, Denfield SD et al (2014) Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol 35:499\u2013506","journal-title":"Pediatr Cardiol"},{"key":"1496_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01954391","volume":"151","author":"MG Bianchetti","year":"1992","unstructured":"Bianchetti MG, Caflisch M, Oetliker OH (1992) Cough and converting enzyme inhibitors. Eur J Pediatr 151:225\u2013226","journal-title":"Eur J Pediatr"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s004679900244","volume":"14","author":"A Delucchi","year":"2000","unstructured":"Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA (2000) Enalapril and prednisone in children with nephrotic-range proteinuria. Pediatr Nephrol 14:1088\u20131091","journal-title":"Pediatr Nephrol"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijporl.2011.07.016","volume":"76","author":"KA Hom","year":"2012","unstructured":"Hom KA, Hirsch R, Elluru RG (2012) Antihypertensive drug-induced angioedema causing upper airway obstruction in children. Int J Pediatr Otorhinolaryngol 76:14\u201319","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.clinthera.2011.09.003","volume":"33","author":"RS Meyers","year":"2011","unstructured":"Meyers RS, Siu A (2011) Pharmacotherapy review of chronic pediatric hypertension. Clin Ther 33:1331\u20131356","journal-title":"Clin Ther"},{"key":"1496_CR15","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1097\/HJH.0b013e32834c625c","volume":"29","author":"F Schaefer","year":"2011","unstructured":"Schaefer F, Litwin M, Zachwieja J, Zurowska A, Turi S, Grosso A et al (2011) Efficacy and safety of valsartan compared to enalapril in hypertensive children. J Hypertens 29:2484\u20132490","journal-title":"J Hypertens"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2012.210","volume":"82","author":"NJA Webb","year":"2012","unstructured":"Webb NJA, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP et al (2012) Losartan and enalapril are comparable in reducing proteinuria in children. Kidney Int 82:819\u2013826","journal-title":"Kidney Int"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/009127002401102786","volume":"42","author":"T Wells","year":"2002","unstructured":"Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P et al (2002) A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 42:870\u2013880","journal-title":"J Clin Pharmacol"},{"key":"1496_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/INF.0000000000000322","volume":"33","author":"D Testoni","year":"2014","unstructured":"Testoni D, Hayashi M, Cohen-Wolkowiez M, Benjamin DK Jr, Lopes RD, Clark RH et al (2014) Late-onset bloodstream infections in hospitalized term infants. Pediatr Infect Dis J 33:920\u2013923","journal-title":"Pediatr Infect Dis J"},{"key":"1496_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0301-2115(99)00196-7","volume":"90","author":"Y Linhart","year":"2000","unstructured":"Linhart Y, Bashiri A, Maymon E, Shoham-Vardi I, Furman B, Vardi H et al (2000) Congenital anomalies are an independent risk factor for neonatal morbidity and perinatal mortality in preterm birth. Eur J Obstet Gynecol Reprod Biol 90:43\u201349","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1496_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/hc4101.096153","volume":"104","author":"AC Schoolwerth","year":"2001","unstructured":"Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104:1985\u20131991","journal-title":"Circulation"},{"key":"1496_CR21","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","volume":"30","author":"MA Raebel","year":"2012","unstructured":"Raebel MA (2012) Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther 30:e156\u2013e166","journal-title":"Cardiovasc Ther"},{"key":"1496_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-0947-6_6","volume-title":"Kidney development in renal pathology","author":"V Fanos","year":"2014","unstructured":"Fanos V, Dessi A, Puddu M, Ottonello G (2014) Perinatal asphyxia and kidney development. In: Faa G, Fanos V (eds) Kidney development in renal pathology. Springer, New York, pp 59\u201366"},{"key":"1496_CR23","first-page":"484","volume":"96","author":"JM Lorenz","year":"1995","unstructured":"Lorenz JM, Kleinman LI, Ahmed G, Markarian K (1995) Phases of fluid and electrolyte homeostasis in the extremely low birth weight infant. Pediatrics 96:484\u2013489","journal-title":"Pediatrics"},{"key":"1496_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/clpt.1994.119","volume":"56","author":"H Nakamura","year":"1994","unstructured":"Nakamura H, Ishii M, Sugimura T, Chiba K, Kato H, Ishizaki T (1994) The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure. Clin Pharm Ther 56:160\u2013168","journal-title":"Clin Pharm Ther"},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00004872-200018020-00001","volume":"18","author":"G Guron","year":"2000","unstructured":"Guron G, Friberg P (2000) An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123\u2013137","journal-title":"J Hypertens"},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/pr.2014.143","volume":"77","author":"LC Ku","year":"2015","unstructured":"Ku LC, Smith PB (2015) Dosing in neonates: special considerations in physiology and trial design. Pediatr Res 77:2\u20139","journal-title":"Pediatr Res"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"F154","DOI":"10.1136\/fn.88.2.F154","volume":"88","author":"G Filler","year":"2003","unstructured":"Filler G, Wong H, Condello AS, Charbonneau C, Sinclair B, Kovesi T et al (2003) Early dialysis in a neonate with intrauterine lisinopril exposure. Arch Dis Child Fetal Neonatal Ed 88:F154\u2013F156","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1496_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/14767050500072862","volume":"17","author":"S Murki","year":"2005","unstructured":"Murki S, Kumar P, Dutta S, Narang A (2005) Fatal neonatal renal failure due to maternal enalapril ingestion. J Matern Fetal Neonatal Med 17:235\u2013237","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.7326\/0003-4819-108-2-215","volume":"108","author":"G Schubiger","year":"1988","unstructured":"Schubiger G, Flury G, Nussberger J (1988) Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate. Ann Intern Med 108:215\u2013216","journal-title":"Ann Intern Med"},{"key":"1496_CR30","first-page":"1047","volume":"48","author":"S Ratnapalan","year":"2002","unstructured":"Ratnapalan S, Koren G (2002) Taking ACE inhibitors during pregnancy. Is it safe? Can Fam Physician 48:1047\u20131049","journal-title":"Can Fam Physician"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/pds.796","volume":"12","author":"S Tabacova","year":"2003","unstructured":"Tabacova S, Little R, Tsong Y, Vega A, Kimmel CA (2003) Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 12:633\u2013646","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1496_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/ndt\/gfi288","volume":"21","author":"G Guron","year":"2006","unstructured":"Guron G, Molne J, Swerkersson S, Friberg P, Hansson S (2006) A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation. Nephrol Dial Transplant 21:522\u2013525","journal-title":"Nephrol Dial Transplant"},{"key":"1496_CR33","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1651-2227.1995.tb13581.x","volume":"84","author":"J Schilder","year":"1995","unstructured":"Schilder J, Van den Anker J (1995) Use of enalapril in neonatal hypertension. Acta Paediatr 84:1426\u20131428","journal-title":"Acta Paediatr"},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0022-3476(05)80711-5","volume":"117","author":"TG Wells","year":"1990","unstructured":"Wells TG, Bunchman TE, Kearns GL (1990) Treatment of neonatal hypertension with enalaprilat. J Pediatr 117:664\u2013667","journal-title":"J Pediatr"},{"key":"1496_CR35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00467-003-1121-5","volume":"18","author":"S Dutta","year":"2003","unstructured":"Dutta S, Narang A (2003) Enalapril-induced acute renal failure in a newborn infant. Pediatr Nephrol 18:570\u2013572","journal-title":"Pediatr Nephrol"},{"key":"1496_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/NPM-1366012","volume":"6","author":"A Russo","year":"2013","unstructured":"Russo A, Mirani A, Perlman J, Miller S (2013) Enalapril-induced acute kidney injury in neonates. J Neonatal Perinatal Med 6:179\u2013181","journal-title":"J Neonatal Perinatal Med"},{"key":"1496_CR37","doi-asserted-by":"publisher","first-page":"299e3","DOI":"10.1016\/j.jpeds.2015.04.059","volume":"167","author":"KO Zimmerman","year":"2015","unstructured":"Zimmerman KO, Hornik CP, Ku L, Watt K, Laughon MM, Bidegain M et al (2015) Sedatives and analgesics given to infants in neonatal intensive care units at the end of life. J Pediatr 167:299e3\u2013304e3","journal-title":"J Pediatr"},{"key":"1496_CR38","first-page":"49","volume":"32","author":"MM Laughon","year":"2015","unstructured":"Laughon MM, Chantala K, Aliaga S, Herring AH, Hornik CP, Hughes R et al (2015) Diuretic exposure in premature infants from 1997 to 2011. Am J Perinatol 32:49\u201356","journal-title":"Am J Perinatol"},{"key":"1496_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.earlhumdev.2015.04.008","volume":"91","author":"D Testoni","year":"2015","unstructured":"Testoni D, Hornik CP, Neely ML, Yang Q, McMahon AW, Clark RH et al (2015) Safety of octreotide in hospitalized infants. Early Hum Dev 91:387\u2013392","journal-title":"Early Hum Dev"},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.earlhumdev.2015.04.001","volume":"91","author":"PY Chu","year":"2015","unstructured":"Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP (2015) Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev 91:345\u2013350","journal-title":"Early Hum Dev"},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1055\/s-0033-1361933","volume":"31","author":"EM Hsieh","year":"2014","unstructured":"Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB et al (2014) Medication use in the neonatal intensive care unit. Am J Perinatol 31:811\u2013821","journal-title":"Am J Perinatol"},{"key":"1496_CR42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0002-8703(96)90365-8","volume":"131","author":"JB Kostis","year":"1996","unstructured":"Kostis JB, Shelton B, Gosselin G, Goulet C, Hood WB Jr, Kohn RM et al (1996) Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J 131:350\u2013355","journal-title":"Am Heart J"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-016-1496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-016-1496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-016-1496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:44:28Z","timestamp":1589679868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-016-1496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s00246-016-1496-2","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]},"assertion":[{"value":"10 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required. Approval for this study was obtained from the Duke University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}